SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it will present at the following investor conferences in March 2018:

• Cowen and Company 38^th Annual Health Care Conference in Boston on March 12 at 11:20 a.m. Eastern Time (ET);
• 28^th Annual Oppenheimer Healthcare Conference in New York City on March 20 at 10:55 a.m. ET; and
• 17^th Annual Needham Healthcare Conference in New York City on March 27 at 11:30 a.m. ET.

The presentations will be webcast live and available for replay from GBT’s website at www.gbt.com in the Investors section.

About GBT
GBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its lead product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. To learn more, please visit www.gbt.com and follow the company on Twitter @GBT_news.

Contact Information:
Myesha Lacy (investors)
GBT
650-351-4730
investor@gbt.com 

Julie Normart (media)
W2Opure
415-946-1087
media@gbt.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.